The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; Boehringer Ingelheim; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Bristol Myers Squibb; Lilly; Merck; Roche
Research Funding - AstraZeneca (Inst); BMS (Inst); Merck (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Lilly
Nitroglycerin (NTG) plus whole intracranial radiotherapy for brain metastases (BM) in non-small cell cancer patient (NSCLC): A randomized open label, phase II clinical trial.
 
Oscar Gerardo Arrieta Rodriguez
No Relationships to Disclose
 
Norma Hernández-Pedro
No Relationships to Disclose
 
Federico Maldonado
No Relationships to Disclose
 
Maritza Ramos
No Relationships to Disclose
 
Masao Yamamoto-Ramos
No Relationships to Disclose
 
Diego López
No Relationships to Disclose
 
Francisco Lozano
No Relationships to Disclose
 
Zyanya Lucía Zatarain-Barron
No Relationships to Disclose
 
Graciela Cruz-Rico
No Relationships to Disclose
 
Pedro Barrios-Bernal
No Relationships to Disclose
 
Mario Orozco-Morales
No Relationships to Disclose
 
Bernardo Cacho
No Relationships to Disclose
 
Diana Flores-Estrada
No Relationships to Disclose
 
Andres Felipe Cardona Zorrilla
Honoraria - Abbvie; Boehringer Ingelheim; Bristol-Myers Squibb; Celldex; Merck Sharp & Dohme; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Foundation for Clinical and Applied Cancer Research (FICMAC); Foundation Medicine; Merck Sharp & Dohme; Novartis; Roche
Speakers' Bureau - Bristol-Myers Squibb; Foundation for Clinical and Applied Cancer Research (FICMAC); Foundation Medicine; Merck Sharp & Dohme; Novartis; Roche
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Foundation Medicine; Merck Sharp & Dohme; Roche
 
Christian Diego Rolfo
Consulting or Advisory Role - Archer; Boston Pharmaceuticals; Bristol-Myers Squibb; Inivata; Merck Serono; Novartis
Speakers' Bureau - AstraZeneca; MSD
Research Funding - Lung Cancer Research Foundation
Travel, Accommodations, Expenses - AstraZeneca
(OPTIONAL) Uncompensated Relationships - Guardant Health